NYSE Euronext announced trading volumes for its global derivatives and cash equities exchanges for March 2013. Overall markets are up Y0Y however the Crpus epidemic had an affect on performance as trading volumes were lower then those of February 2013. Global derivatives average daily volume (“ADV”) of 8.1 million contracts in March 2013 was in-line with March 2012, but decreased 7.8% from February 2013. European derivatives products ADV in March 2013 of 4.3 million contracts increased 8.9% compared to March 2012, but decreased 2.8% from February 2013 levels. NYSE Liffe U.S. rebounded 62.7% versus the prior month. Trading volumes in European and U.S. cash equities declined both year-over-year and month-over-month.
- European Derivatives ADV Up Nearly 9% versus Prior Year
- European, U.S. Cash Equities and U.S. Equity Options ADV Trail Prior Year
NYSE Euronext global derivatives ADV in March 2013 of 8.1 million contracts was in line with March 2012, and decreased 7.8% from February 2013 levels.
The NYSE share price is trading at 37.81 in USA.
NYSE Euronext European derivatives products ADV in March 2013 of 4.3 million contracts increased 8.9% compared to March 2012, but decreased 2.8% from February 2013 levels. Excluding Bclear, NYSE Liffe’s trade administration and clearing service for OTC products, European derivatives products ADV increased 21.4% compared to March 2012, but decreased 6.7% from February 2013.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.8 million contracts in March 2013 decreased 8.6% compared to March 2012 levels, and decreased by 13.7% from February 2013 levels. NYSE Euronext’s U.S. options exchanges accounted for 26.9% of total U.S. consolidated equity options trading in March 2013, up from 26.0% in March 2012, but down from 28.2% in February 2013.
NYSE Liffe U.S. ADV of approximately 78,100 contracts decreased from 104,900 contracts in March 2012, but increased from 48,000 contracts in February 2013.
Legal Risk Factor Beneath Ripple’s Lawsuit from SECGo to article >>
NYSE Euronext European cash products ADV of 1.4 million transactions in March 2013 decreased 14.4% compared to March 2012 and decreased 4.6% compared to February 2013.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE-MKT) handled ADV of 1.5 billion shares in March 2013 decreased 13.8% compared to March 2012 and decreased 2.7% compared to February 2013. NYSE Euronext’s Tape A matched market share in March 2013 was 31.1%, down slightly from 31.3% in March 2012, but up from 29.4% in February 2013.
There were no large one-time managed services sales in the first quarter of 2013 for the Information Services and Technology Solutions segment, as were recorded in the fourth quarter with the ATG sale and in the first quarter of 2012 with the technology sale to the Warsaw Stock Exchange. However, our market data initiatives are on track to start building in April 2013.
In the first quarter, we incurred an incremental $3.5 million pre-tax charge related to cash-settled restricted stock unit awards, as a result of the increase in our stock price.
The average EUR/USD exchange rate for the first quarter of 2013 of $1.32 represented an increase of 1.7% from the fourth quarter of 2012 and an increase of 0.7% compared to the first quarter of 2012. The average GBP/USD exchange rate for the first quarter of 2013 of $1.55 represented a decrease of 3.4% from the fourth quarter of 2012 and a decrease of 1.2% compared to the first quarter of 2012.